CN107475378A - For detecting the PATL2 genes of women primary infertility and detecting the kit of the gene mutation - Google Patents
For detecting the PATL2 genes of women primary infertility and detecting the kit of the gene mutation Download PDFInfo
- Publication number
- CN107475378A CN107475378A CN201710657304.9A CN201710657304A CN107475378A CN 107475378 A CN107475378 A CN 107475378A CN 201710657304 A CN201710657304 A CN 201710657304A CN 107475378 A CN107475378 A CN 107475378A
- Authority
- CN
- China
- Prior art keywords
- seq
- patl2
- genes
- ovum
- detecting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Abstract
The invention belongs to technical field of gene detection, particularly for the kit of the PATL2 gene mutations of detection women primary infertility.Mankind PATL2 genes of the present invention, it is the reason for causing to cause female acyesis because ovum is immature during its mutation.Mutation by detecting PATL2 genes can be used as the marker gene for judging that female acyesis is caused because ovum is immature.It can be used for evaluation using PATL2 gene mutations provided by the invention or prepare because of the kit for screening of the immature cause female acyesis of ovum.Using PATL2 gene mutations provided by the invention whether, available for instruct clinical respective patient whether properly carry out test-tube baby's art.
Description
Technical field
The invention belongs to technical field of gene detection, and in particular to a kind of PATL2 bases for being used to detect women primary infertility
Cause and the kit for detecting the gene mutation.
Background technology
Normal pregnancy and reproduction are maintenance and the important step for continuing human population.For female acyesis, have at present
The genes such as ZP-1, Stag3, FSHR are found closely related with female infertility(Huang HL et al, Mutant ZP1 in
familial infertility. N Engl J Med. 2014 370(13):1220-6;de Roux N et al, A
family with hypogonadotropic hypogonadism and mutations in the gonadotropin-
releasing hormone receptor. N Engl J Med. 1997 337(22):1597-602;Caburet S et
al, Mutant cohesion in premature ovarian failure. N Engl J Med.2014 370(10):
943-9).But do not applied in clinic.
The reason for causing female infertility, is a lot, has some clinical reports to be related to women characterized by ovum is immature not
The description of pregnant disease(Rudak et al, fertility and sterility,1990 54:292-296;Human
Reproduction,1995 10:2343-2349; fertility and sterility 1999 71:567-570;Human
Reproduction 2001 16(10):2136-2138;Human Reproduction 2002 17(6):1604-1609;
Human Reproduction 2002 17(10):2556-2559).These patients are by being repeated insemination-transplantation of embryo
(Test-tube baby), because failing to get ripe egg cell, and successful inseminatio externalis operation can not be completed.If phase can be found
Close Disease-causing gene, then it is all significant to disease clinical diagnosis and parting.Recently, we found that cause mankind ovum into
First Disease-causing gene TUBB8 (Jan 21 of N Engl J Med. 2016 of ripe obstacle;374(3):223-32).But this
The reason for gene is only capable of explaining some patientss, it is still unknown the reason for quite a lot of patient.
Find by prior art documents, only find that a several pieces surround the research article of PATL2 gene functions.
These researchs cause Xenopus Oocytes ripe abnormal after reporting this gene overexpression.But so far there are no on
Any report of relation between PATL2 gene mutations and human diseases.Its report related to female infertility is not found yet.
The content of the invention
It is an object of the invention to provide a kind of easy to operate, definite effect for detecting women primary infertility
PATL2 genes and the kit for detecting the gene mutation.
The nucleotide sequence such as SEQ ID NO.1 institutes proposed by the present invention for being used to detect the PATL2 genes of women primary infertility
Show.
The present invention relates to the method that examination causes primary infertility because ovum is immature, exactly by detecting PATL2 genes
Whether undergo mutation judge patient whether be ovum it is immature caused by primary infertility.Patient carries PATL2 genes and dashed forward
Change shows as infertile, and showing as ovum all the time can not ripe and test-tube baby failure.
It can be seen that PATL2 genes whether undergo mutation can as judge because ovum it is immature cause female acyesis mark.
Whether detection PATL2 genes undergo mutation method, after specifically can extracting DNA from the peripheral blood of patient, use PCR
(Polymerase chain reaction)Method combination DNA sequencing, to detect whether PATL2 genes are mutated.
Wherein, the sample of detection is DNA, and the DNA sample comes from the peripheral blood of crowd to be checked.
Or the sample of detection is RNA, albumen, cell or serum sample, the sample comes from the periphery of crowd to be checked
Blood.
The present invention relates to the primer whether detection PATL2 genes undergo mutation.
PATL2 genes have 15 extrons, for detect the 1st extron pcr amplification primer thing to for:
5’- CTGGGAGGATTCCATGGCTG-3’(SEQ ID NO.2)
5’- ATATGAGGCTGTCCTGGGTTG-3’(SEQ ID NO.3)
Sequencing primer is to ibid;
For detect the 2nd exon pcr amplification primer thing to for:
5’-CTTACTGGGGGATGGTTCGG-3’(SEQ ID NO.4)
5’-GCCACAGACAGTTCAGGACA-3’(SEQ ID NO.5)
Sequencing primer is to ibid;
For detect the 3rd exon pcr amplification primer thing to for:
5’-TCCTCCCAGGAGAGGGAGA -3’(SEQ ID NO.6)
5’-CCTCTATGATGGGGCAACTCC -3’(SEQ ID NO.7)
Sequencing primer is to ibid;
For detect the 4th exon pcr amplification primer thing to for:
5’-CTGCTTCCTAGTCAAGCCCT-3’(SEQ ID NO.8)
5’-TGGCAACTGGTAGGCATGG-3’(SEQ ID NO.9)
Sequencing primer is to ibid;
For detect the 5th, 6 exon pcr amplification primer thing to for:
5’-GCTGACCTGGGCTGAATGAA-3’(SEQ ID NO.10)
5’-CGAAGAGAGGATCAGAGCGG -3’(SEQ ID NO.11)
Sequencing primer is to ibid;
For detect the 7th, 8 exon pcr amplification primer thing to for:
5’-AGAGGGAGATGCTGTCTCAAAC-3’(SEQ ID NO.12)
5’-GGCCCCCAACTAGCTAGAGAT-3’(SEQ ID NO.13)
Sequencing primer is to ibid;
For detect the 9,10th exon pcr amplification primer thing to for:
5’-GACTGTGACCGAAGAAGGAGG -3’(SEQ ID NO.14)
5’-GAGAGGGCTACATGCCACAA -3’(SEQ ID NO.15)
Sequencing primer is to ibid;
For detect the pcr amplification primer thing of o.11 extron to for:
5’-AGGAGCAGCAAAGACACTGG -3’(SEQ ID NO.16)
5’-GACCTCCTCAGCACACTGAC -3’(SEQ ID NO.17)
Sequencing primer is to ibid;
For detect the 12nd exon pcr amplification primer thing to for:
5’-TAGGTACCGAAGGTGTCAGTGT -3’(SEQ ID NO.18)
5’-GTAGAGATGAGACTGTCCCCCA -3’(SEQ ID NO.19)
Sequencing primer is to ibid;
For detect the 13rd exon pcr amplification primer thing to for:
5’-TTGGCTCACCAGTGTAAAACCT -3’(SEQ ID NO.20)
5’-TAGAAGAAACCGAAACTCTAGGGC -3’(SEQ ID NO.21)
Sequencing primer is to ibid;
For detect the 14th exon pcr amplification primer thing to for:
5’-GTGGGGGACAATGGTAGTAGT -3’(SEQ ID NO.22)
5’-ATGACCAAAGCACCTGGAATAAAA -3’(SEQ ID NO.23)
Sequencing primer is to ibid;
For detect the 15th exon pcr amplification primer thing to for:
5’-AGTGCTAACCTATTTGAGGGCA -3’(SEQ ID NO.24)
5’-TGCCATGTCTTATTTTTAGGCACA -3’(SEQ ID NO.25)
Sequencing primer is to ibid.
It is specific as follows the invention further relates to the method whether detection PATL2 genes undergo mutation:
To wherein 1 exon, primer pair is utilized:SEQ ID NO.2, SEQ ID NO.3, enter performing PCR amplification(Amplification condition:
92 DEG C 2 minutes, 92 DEG C 30 seconds, 57 DEG C 1 minute, 72 DEG C 3 seconds(This three step repeats 35 circulations), 72 DEG C 10 minutes), so
It is sequenced afterwards using identical primer, the standard sequence with PATL2 in UCSC(SEQ ID NO.1)It is compared, so as to send out
Now it is mutated;
It is similar to above-mentioned condition, PATL2 2-15 exons, (SEQ ID NO.4- are expanded by corresponding primer
NO.25)
It is sequenced, then the standard sequence with PATL2 in UCSC(SEQ ID NO.1)It is compared, so as to find to be mutated.Pass through
PCR and generation sequencing, and the comparison with standard sequence, to detect whether PATL2 genes undergo mutation.
The present invention also provides the detection kit whether PATL2 genes undergo mutation.This kit can instruct doctor couple
The judgement of the disease cause of disease, disease is correctly classified, so as to inform that patient carries out test-tube baby using IVF methods or ICSI methods
Operation, and if appropriate for continue implement IVF-ET cycle art(IVF)Or intracytoplasmic sperm injection art(ICSI)(Test tube baby
Youngster).
Kit provided by the invention, include the amplimer SEQ ID of above-mentioned amplification PATL2 1-15 exons
NO.2-SEQ ID NO.25, and reaction mixture;Reaction mixture includes archaeal dna polymerase, dNTP and buffer solution;
Specifically used method is:Primer is diluted with water as the working solution of 10uM concentration.Reaction system is 10ul, wherein, 1ul
Sample DNA, 0.5ul forward primers, 0.5ul reverse primers, 5ul reaction mixtures and 3ul water composition.After mixing, by above-mentioned
Condition enters performing PCR reaction, then carries out generation sequencing.
Mentioned reagent box can be used for the immature examination for causing primary infertility of detection ovum.
The present invention is also provided for studying the immature gene repair target site for causing primary infertility of drug therapy ovum(I.e.
It is actually detected go out patient mutational site, for example 9 mutational sites are listed in table 1, during actually detected, by with
Standard sequence compares, and may have new mutational site), and by the reparation to target site, so that PATL2 can go
Make normal function, and then such a disease can be treated.I.e. the present invention, which can also provide to study, is used for repair gene mutation target site
Medicine, that is, treat ovum it is immature cause primary infertility medicine.
The present invention can also instruct the clinical patient with this gene mutation, if close by detecting the mutation of PATL2 genes
It is suitable to carry out test-tube baby's art.In routine clinical, the Infertile couples of unknown cause need to carry out test-tube baby to attempt to produce offspring.
But if patient has found the mutation with PATL2 by detecting, then this patient can fail if test-tube baby's art is attempted.
Because the ovum of the patient with this mutation is operation that is jejune, thus can not completing follow-up test-tube baby.Therefore, build
Discuss such patient and carry out tax ovum.
Brief description of the drawings
Fig. 1 is the distribution displaying that patient is mutated in PATL2 primary structures.
Embodiment
Below in conjunction with specific embodiment, to further illustrate the present invention.It should be understood that following examples are merely to illustrate this hair
Bright rather than limitation the scope of the present invention.
Embodiment 1:The collection of sample and the extracting of peripheral blood DNA
Ovum is immature to cause primary infertility patient to come from the attached red house hospital Shanghai collection love something lost of Chinese Shanghai Fudan University
Pass and sterile diagnosis and treatment center, the attached 9th the People's Hospital's reproductive center of Chinese Shanghai university of communications.Diagnostic criteria is by Rudak E etc.
People(Rudak E., DorJ.,KimchiM.,Goldman B.,Levran D and Mashiach S, Anomalies of
human oocytes from infertile women undergoing treatment by in vitro
fertilization. FertilSteril. 1990 Aug; 54(2):292-6)It is proposed.Bridegroom's or husband's side semen efamination is normal, the wife's side
Patient female reproductive organ, ovarian function, sex hormone are normal, and more than 2 times decorporation cycles get more than 5 ovums, ovum every time
Son is mostly in the GV phases, it is impossible to carries out normal meiosis and maturation.This problem is participated on the premise of informed consent
Research, blood is gathered, and sign informed consent form.All patients in group exclude other Procreation models by medical history.
The control crowd of this experiment is 1000 normal women of reproductive function, takes sample blood 300ul, is extracted by kit specification
DNA, DNA concentration and purity are detected with UV detector.
Embodiment 2:Detect the mutation of PATL2 genes
The present invention combines the searching of sequencing progress PATL2 gene mutations using PCR.Its principle is first to 15 of PATL2 genes
Extron carries out design of primers(Primer sequence can be specifically given)And amplification, carry out the searching of PATL2 gene mutations.(I.e. by DNA
Sample and reaction working solution(Archaeal dna polymerase, dNTP, water and buffer solution)Mix after mixing, expanded according to PCR programs.Institute
Product is obtained, by purifying and further sequencing reaction, is sequenced in ABI3730 sequencings.Interpretation of result is soft by HLA Fusion
Part (One lambda, CA, USA, HLA Fusion 3.0) is carried out.
Embodiment 3:PATL2 gene mutations because ovum is immature with causing primary infertility
As a result:It is immature and cause primary infertility patient 5 that we collected PATL2 gene mutations institute reason ovum altogether.It is corresponding prominent
Become site information see the table below(Table 1).Distribution of the mutational site in structure is as shown in Figure 1.
The patient P ATL2 gene mutation information of table 1
In summary, it is of the invention that there is following important practical usage:
(1)The marker gene of female acyesis can be caused because ovum is immature by the use of PATL2 genes proposed by the present invention as prediction;
(2)It can be used for evaluation using PATL2 genes provided by the invention or prepare because of the examination of the immature cause female acyesis of ovum
Kit;
(3)Using the present invention, the medicine for preparing repair gene mutation target site can be studied, that is, it is primary to treat the immature cause of ovum
The infertile medicine of property;
(4)It can be used for instructing the clinical patient with this gene mutation using PATL2 genes provided by the invention, judge test tube baby
The successful possibility of youngster, and suggest carrying out follow-up tax ovum.
SEQUENCE LISTING
<110>Fudan University
<120>For detecting the PATL2 genes of women primary infertility and detecting the kit of the gene mutation
<130> 001
<160> 25
<170> PatentIn version 3.3
<210> 1
<211> 1632
<212> DNA
<213>
<400> 1
atgaattgcc ttgaagggcc aggtaagacc tgtggcccct tggcttctga ggaggagctg 60
gtgtctgcct gccagttgga aaaagaagaa gagaatgaag gggaggagga ggaagaggag 120
gaggacgagg aggatctgga cccagatctg gacccagacc tagaggagga agagaatgat 180
cttggggatc cagctgtact tggtgctgtc cacaacaccc agagagctct gcttagctcc 240
cctggagtca aggcccctgg tatgctggga atgtcacttg cctccttgca ttttctgtgg 300
cagaccttgg actacctgtc gcccatccct ttctggccta catttcccag caccagctct 360
ccagcacagc actttggacc tcggctgccc tcaccagacc caactctctt ctgcagcctg 420
ctgacctcgt ggccccctag gttcagtcat ctgacccagc tccaccctcg gcaccaacga 480
atcttgcagc agcagcagca tagtcaaaca ccaagtcccc cagccaagaa gccttggtct 540
cagcagccag acccctatgc taacctcatg accagaaaag agaaggactg ggtgataaaa 600
gtgcagatgg tgcagctgca gagtgcaaaa ccccgcctgg atgactacta ttaccaggaa 660
tattaccaga agctagagaa gaagcaggca gacgaagagc tacttggacg aagaaaccgg 720
gttgagtccc tcaagctggt aacgccttac attccgaagg cagaggctta tgagtccgtg 780
gtccgaatcg agggttccct gggccaggta gctgtgtcga catgcttcag ccctcgccga 840
gctattgatg cggtacccca tggaactcaa gagcaggata tagaagctgc aagcagtcag 900
aggcttcggg tattataccg gattgagaag atgttccttc agttactaga aatagaggaa 960
ggctggaagt ataggcctcc accgccctgc ttttctgagc agcaaagcaa ccaggttgag 1020
aagctcttcc agaccttaaa gacccaggag cagaacaacc tggaagaggc agcagatggc 1080
ttcctgcagg tgctctctgt gaggaagggg aaggccctgg tggcccggct gctccccttc 1140
ctgccccagg atcaggctgt taccattctt ttggctatca cccaccatct gcccctcctg 1200
gtccggaggg atgtggctga tcaggcccta caaatgttat tcaaacctct gggcaaatgt 1260
attagtcact tgaccctcca cgaactcctc caaggacttc agggattaac gctgttgcca 1320
cctggctcct cagagcggcc agtcaccgtg gtgcttcaga atcagtttgg aatatctttg 1380
ctctatgccc tgctgagcca tggggagcaa ctggtatcgc tgcattcttc cctagaggaa 1440
cccaacagtg accatacagc ttggacagac atggtggttc tgattgcctg ggagatagcc 1500
caaatgccta cagcctctct ggcagaaccc ctagctttcc ccagcaacct acttcccctg 1560
ttctgtcacc acgtggacaa acaattggtt cagcagctgg aggccaggat ggagtttgcc 1620
tggatttact ga 1632
<210> 2
<211> 20
<212> DNA
<213>
<400> 2
ctgggaggat tccatggctg 20
<210> 3
<211> 21
<212> DNA
<213>
<400> 3
atatgaggct gtcctgggtt g 21
<210> 4
<211> 20
<212> DNA
<213>
<400> 4
cttactgggg gatggttcgg 20
<210> 5
<211> 20
<212> DNA
<213>
<400> 5
gccacagaca gttcaggaca 20
<210> 6
<211> 19
<212> DNA
<213>
<400> 6
tcctcccagg agagggaga 19
<210> 7
<211> 21
<212> DNA
<213>
<400> 7
cctctatgat ggggcaactc c 21
<210> 8
<211> 20
<212> DNA
<213>
<400> 8
ctgcttccta gtcaagccct 20
<210> 9
<211> 19
<212> DNA
<213>
<400> 9
tggcaactgg taggcatgg 19
<210> 10
<211> 20
<212> DNA
<213>
<400> 10
gctgacctgg gctgaatgaa 20
<210> 11
<211> 20
<212> DNA
<213>
<400> 11
cgaagagagg atcagagcgg 20
<210> 12
<211> 22
<212> DNA
<213>
<400> 12
agagggagat gctgtctcaa ac 22
<210> 13
<211> 21
<212> DNA
<213>
<400> 13
ggcccccaac tagctagaga t 21
<210> 14
<211> 21
<212> DNA
<213>
<400> 14
gactgtgacc gaagaaggag g 21
<210> 15
<211> 20
<212> DNA
<213>
<400> 15
gagagggcta catgccacaa 20
<210> 16
<211> 20
<212> DNA
<213>
<400> 16
aggagcagca aagacactgg 20
<210> 17
<211> 20
<212> DNA
<213>
<400> 17
gacctcctca gcacactgac 20
<210> 18
<211> 22
<212> DNA
<213>
<400> 18
taggtaccga aggtgtcagt gt 22
<210> 19
<211> 22
<212> DNA
<213>
<400> 19
gtagagatga gactgtcccc ca 22
<210> 20
<211> 22
<212> DNA
<213>
<400> 20
ttggctcacc agtgtaaaac ct 22
<210> 21
<211> 24
<212> DNA
<213>
<400> 21
tagaagaaac cgaaactcta gggc 24
<210> 22
<211> 21
<212> DNA
<213>
<400> 22
gtgggggaca atggtagtag t 21
<210> 23
<211> 24
<212> DNA
<213>
<400> 23
atgaccaaag cacctggaat aaaa 24
<210> 24
<211> 22
<212> DNA
<213>
<400> 24
agtgctaacc tatttgaggg ca 22
<210> 25
<211> 24
<212> DNA
<213>
<400> 25
tgccatgtct tatttttagg caca 24
Claims (5)
1. whether PATL2 genes undergo mutation as the application for judging the mark that female acyesis is caused because ovum is immature, described
The nucleotide sequence of PATL2 genes is as shown in SEQ ID NO.1.
2. a kind of method that examination causes primary infertility because ovum is immature, it is characterised in that be by detecting PATL2 genes
It is no undergo mutation judge patient whether be ovum it is immature caused by primary infertility.
3. for detecting the primer whether PATL2 genes undergo mutation, it is characterised in that for aobvious outside 15 of PATL2 genes
Son, the pcr amplification primer thing of detection is to being followed successively by:SEQ ID NO.2, SEQ ID NO.3, SEQ ID NO.4, SEQ ID
NO.5, SEQ ID NO.6, SEQ ID NO.7, SEQ ID NO.8, SEQ ID NO.9, SEQ ID NO.10, SEQ ID
NO.11, SEQ ID NO.12, SEQ ID NO.13, SEQ ID NO.14, SEQ ID NO.15, SEQ ID NO.16, SEQ ID
NO.17, SEQ ID NO.18, SEQ ID NO.19, SEQ ID NO.20, SEQ ID NO.21, SEQ ID NO.22, SEQ ID
NO.23, SEQ ID NO.24, SEQ ID NO.25.
4. a kind of method whether detection PATL2 genes undergo mutation, it is characterised in that comprise the following steps that:
To 15 exons in PATL2, corresponding primer pair SEQ ID NO.2, SEQ ID NO.3--SEQ ID are utilized respectively
NO.24, SEQ ID NO.25, enter performing PCR amplification, be then sequenced using identical primer, the standard with PATL2 in UCSC
Sequence:SEQ ID NO.1 are compared, so as to find to be mutated.
5. a kind of be used to detect the kit whether PATL2 genes undergo mutation, it is characterised in that kit includes amplification
The amplimer and corresponding sequencing primer of the 1-15 exons of PATL2 genes:SEQ ID NO.2-SEQ ID NO.25,
And reaction mixture, reaction mixture include archaeal dna polymerase, dNTP and buffer solution.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710657304.9A CN107475378B (en) | 2017-08-03 | 2017-08-03 | PATL2 gene for detecting female primary infertility and kit for detecting gene mutation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710657304.9A CN107475378B (en) | 2017-08-03 | 2017-08-03 | PATL2 gene for detecting female primary infertility and kit for detecting gene mutation |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107475378A true CN107475378A (en) | 2017-12-15 |
CN107475378B CN107475378B (en) | 2021-03-30 |
Family
ID=60596993
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710657304.9A Active CN107475378B (en) | 2017-08-03 | 2017-08-03 | PATL2 gene for detecting female primary infertility and kit for detecting gene mutation |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107475378B (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109504761A (en) * | 2018-12-12 | 2019-03-22 | 复旦大学 | It detects the PANX1 gene of women primary infertility and detects the kit of the gene mutation |
CN111500723A (en) * | 2020-04-28 | 2020-08-07 | 广州达康基因技术有限公司 | Marker combination for detecting premature ovarian failure genes and detection kit |
CN112877415A (en) * | 2019-12-01 | 2021-06-01 | 复旦大学 | Marker TRIP13 gene for judging female primary infertility and detection kit thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012158561A1 (en) * | 2011-05-13 | 2012-11-22 | The United States Of America As Represented By The Secretary, Dept. Of Health And Human Services | Use of zscan4 and zscan4-dependent genes for direct reprogramming of somatic cells |
-
2017
- 2017-08-03 CN CN201710657304.9A patent/CN107475378B/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012158561A1 (en) * | 2011-05-13 | 2012-11-22 | The United States Of America As Represented By The Secretary, Dept. Of Health And Human Services | Use of zscan4 and zscan4-dependent genes for direct reprogramming of somatic cells |
Non-Patent Citations (1)
Title |
---|
GENEBANK: ""NM_001145112.1"", 《GENEBANK》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109504761A (en) * | 2018-12-12 | 2019-03-22 | 复旦大学 | It detects the PANX1 gene of women primary infertility and detects the kit of the gene mutation |
CN112877415A (en) * | 2019-12-01 | 2021-06-01 | 复旦大学 | Marker TRIP13 gene for judging female primary infertility and detection kit thereof |
CN111500723A (en) * | 2020-04-28 | 2020-08-07 | 广州达康基因技术有限公司 | Marker combination for detecting premature ovarian failure genes and detection kit |
Also Published As
Publication number | Publication date |
---|---|
CN107475378B (en) | 2021-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Carrasquillo et al. | Advanced paternal age does not affect embryo aneuploidy following blastocyst biopsy in egg donor cycles | |
EP1633884A1 (en) | Identification of clonal cells by repeats in (eg.) t-cell receptor v/d/j genes | |
CN107475378A (en) | For detecting the PATL2 genes of women primary infertility and detecting the kit of the gene mutation | |
CN104212806B (en) | New mutant disease-causing gene of Alport syndrome, encoded protein and application thereof | |
Liatsikos et al. | HOX A10 and HOX A11 mutation scan in congenital malformations of the female genital tract | |
Fan et al. | The clinical utility of next-generation sequencing for identifying chromosome disease syndromes in human embryos | |
CN104498614A (en) | Probe and non-invasive kit for detecting pseudo-hypertrophic muscular dystrophy | |
CN109371018A (en) | For dissociate Circulating tumor DNA extraction reinforcing agent, extract peripheral blood in dissociate Circulating tumor DNA kit and method | |
CN110029158A (en) | A kind of marfan's syndrome detection panel and its application | |
CN105296637A (en) | Primers, probes and kit for detecting leukemia-related fusion genes | |
CN105296634B (en) | For detecting the VIII type 'beta '-tubulin gene and kit of women primary infertility | |
CN109055532A (en) | Hereditary hearing impairment genetic test Primer composition, kit and application before embryo implantation | |
CN109504761A (en) | It detects the PANX1 gene of women primary infertility and detects the kit of the gene mutation | |
CN110438220A (en) | The motionless syndrome gene panel kit of cilium and its application | |
CN111549036A (en) | Marker BTG4 gene for judging female primary infertility and detection kit thereof | |
Lammers et al. | Morphokinetic parameters in chromosomal translocation carriers undergoing preimplantation genetic testing | |
CN112877414A (en) | Marker CDC20 gene for judging female primary infertility and detection kit thereof | |
CN112877415A (en) | Marker TRIP13 gene for judging female primary infertility and detection kit thereof | |
Song et al. | Genome-wide screening of severe male factor infertile patients using BAC-array comparative genomic hybridization (CGH) | |
CN109055533B (en) | Primer combination, detection method and kit for detecting ATP7B gene mutation | |
Wang et al. | De novo paternal FBN1 mutation detected in embryos before implantation | |
JP2004275115A (en) | Mutation of scn2a gene in intractable childhood epilepsy accompanied by involution of critical mental faculty | |
Yovinska et al. | Conference: Interactive e-Posters | |
CN117004703A (en) | KPNA7 gene for detecting female primary infertility and kit for detecting mutation of KPNA7 gene | |
CN117004702A (en) | LHX8 gene for detecting female primary infertility and kit for detecting mutation of gene |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Wang Lei Inventor after: Chen Biaobang Inventor after: Sang Qing Inventor after: Xu Yao Inventor after: Mu Jian Inventor before: Wang Lei Inventor before: Chen Biaobang Inventor before: Sang Qingxu Inventor before: Yao Mujian |
|
GR01 | Patent grant | ||
GR01 | Patent grant |